About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD31.18
- USD33.16
- USD30.84
- USD41.04
- 17.30%
- 218M
- 1.00
- 3.49M
- 6.5B
- 21.62
- -2.70%
Stock News
3 hours ago
Morgan Stanley’s finally given up on the idea the Fed will cut in March. What went wrong.
MarketWatch
8 hours ago
In The Hunt For Income, It's Wise To Broaden Your Horizons
SeekingAlpha
8 hours ago
MSOS: High Risk/Reward On The Cannabis Market
SeekingAlpha
9 hours ago
Q4 2024 Economic Update
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
